Kim Sablich's Net Worth
$5.67 Million
Who is Kim Sablich?
Kim Sablich has an estimated net worth of $5.67 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Eiger BioPharmaceuticals, Inc., and Jazz Pharmaceuticals plc.
SEC CIK
Kim Sablich's CIK is 0001758790
Past Insider Trading and Trends
2020 was Kim Sablich's most active year for acquiring shares with 5 total transactions. Kim Sablich's most active month to acquire stocks was the month of July. 2022 was Kim Sablich's most active year for disposing of shares, totalling 8 transactions. Kim Sablich's most active month to dispose stocks was the month of May. 2020 saw Kim Sablich paying a total of $0.00 for 281,069 shares, this is the most they've acquired in one year. In 2021 Kim Sablich cashed out on 4,200 shares for a total of $627,234.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myovant Sciences Ltd. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +149.06% | 87.81K |
—
|
—
| 146.71K |
Apr 3
| |||
Form 4
| -1.32% | -785.00 |
$7.37 | -$5,786.55 | 58.91K |
Mar 18
| |||
Form 4
| -7.50% | -4.84K |
$14.04 | -$67,953.60 | 59.69K |
Scheduled
|
Jan 15
| ||
Form 4
| -3.85% | -2.58K |
$16.22 | -$41,928.70 | 64.53K |
Dec 18
| |||
Form 4
| +125.98% | 37.41K |
—
|
—
| 67.11K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
∞
| 29.7K |
—
|
—
| 29.7K |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
EVP, GM U.S.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.81% | -2.08K |
$129.73 | -$270,097.86 | 28.48K |
Jun 5
| |||
Form 4
| -8.97% | -3.01K |
$139.74 | -$421,043.43 | 30.56K |
Scheduled
|
Mar 8
| ||
Form 4
| +35.63% | 8.82K |
$142.78 | -$229,875.80 | 33.57K |
Mar 3 - Mar 5
| |||
Form 4
| -18.42% | -5.59K |
$150.76 | -$842,428.50 | 24.75K |
Scheduled
|
Jun 6 - Jun 7
| ||
Form 4
| +43.56% | 9.21K |
$153.96 | -$114,854.16 | 30.34K |
Mar 3 - Mar 5
| |||
Form 4
| -11.51% | -2.75K |
$135.01 | -$371,000.34 | 21.14K |
Nov 11
| |||
Form 4
| -5.73% | -1.45K |
$176.47 | -$256,234.44 | 23.88K |
Jun 5
| |||
Form 4
| +50.80% | 8.54K |
—
|
—
| 25.34K |
Feb 25
| |||
Form 4
|
∞
| 16.8K |
—
|
—
| 16.8K |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||